Dr Paul Mulholland, Oncology - London

Dr Mulholland is a medical oncologist who exclusively treats brain cancer - he is a current consultant at University College Hospital and is the chair of the HCA cancer care brain and CNS tumour board. He is also an honorary senior lecturer at UCL and a training programme director.

His doctoral research was in genomic profiling in brain cancer at Cancer Research UK - this has led to his focus on developing biomarkers and targets for therapy in brain cancer, including the clinical trial portfolio of novel agents in brain cancer which he now runs at UCLH and nationally.

He is a clinical lead in a European Consortium called Datrix, a multidisciplinary European collaboration to advance next-generation targeted hyperthermic cancer treatment for glioblastoma.

+ Read More

Medical Procedures

Cancer prevention and screening
chemotherapy
bone marrow transplant

+ Read More

Special Interests

Brain Cancer
Head and neck cancer
neuro-endocrine tumours
Central nervous system cancer
novel agents

Education

Education:

University of London - MBBS - 1992

Memberships:

London Cancer Brain and Spine pathway
Royal Society of Medicine Oncology
French National Cancer Institute Funding Committee

Reviews

BY A VERIFIED PATIENT

03-04-2019

Very calm

Peer Recommendations

BY mr Neil Kitchen

25-03-2019

Dr Mulholland is a medical oncologist at the National Hospital for Neurology and Neurosurgery who exclusively treats brain cancer, using novel agents and therapies.

For specialty: Oncology

For conditions: Head & Neck Cancers

Connection: Is a colleague